27.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$26.81
Offen:
$27.15
24-Stunden-Volumen:
2.90M
Relative Volume:
1.07
Marktkapitalisierung:
$12.52B
Einnahmen:
Nettoeinkommen (Verlust:
KGV:
-
EPS:
-
Netto-Cashflow:
1W Leistung:
+3.57%
1M Leistung:
+4.08%
6M Leistung:
-6.76%
1J Leistung:
+1.34%
Brown Forman Corporation Stock (BF.B) Company Profile
Firmenname
Brown Forman Corporation
Sektor
Telefon
502 585 1100
Adresse
850 Dixie Highway, Louisville
Compare BF.B vs DEO, BF.A, AGCC, MGPI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BF.B
Brown Forman Corporation
|
27.29 | 12.52B | 0 | 0 | 0 | 0.00 |
|
DEO
Diageo Plc Adr
|
90.43 | 50.29B | 19.85B | 2.57B | 2.53B | 4.3222 |
|
BF.A
Brown Forman Corp
|
27.79 | 12.75B | 3.94B | 715.00M | 893.00M | 1.5278 |
|
AGCC
Agencia Comercial Spirits Ltd
|
15.36 | 657.20M | 6.21M | 609.40K | -7.50M | 0.0178 |
|
MGPI
Mgp Ingredients Inc
|
14.61 | 312.86M | 521.15M | -238.35M | 54.02M | -11.15 |
Brown Forman Corporation Stock (BF.B) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-06-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2026-06-08 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2026-06-05 | Fortgesetzt | Morgan Stanley | Underweight |
| 2026-04-29 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2026-03-27 | Hochstufung | Citigroup | Sell → Neutral |
| 2026-03-27 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-03-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2026-01-16 | Herabstufung | BNP Paribas Exane | Neutral → Underperform |
| 2025-12-17 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-11-07 | Fortgesetzt | JP Morgan | Underweight |
| 2025-07-09 | Hochstufung | Rothschild & Co Redburn | Sell → Neutral |
| 2025-06-06 | Herabstufung | BNP Paribas Exane | Outperform → Neutral |
| 2025-04-09 | Hochstufung | ROTH MKM | Neutral → Buy |
| 2025-04-02 | Eingeleitet | Berenberg | Hold |
| 2025-03-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-12-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-12-16 | Herabstufung | Truist | Buy → Hold |
| 2024-12-06 | Eingeleitet | Needham | Hold |
| 2024-11-25 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2024-11-06 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-09-30 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-04-02 | Hochstufung | Citigroup | Sell → Neutral |
| 2024-01-29 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-09-11 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-08-31 | Bestätigt | ROTH MKM | Neutral |
| 2023-08-23 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2023-06-08 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2023-03-09 | Fortgesetzt | Morgan Stanley | Underweight |
| 2023-02-17 | Eingeleitet | Citigroup | Sell |
| 2022-10-11 | Eingeleitet | Wedbush | Neutral |
| 2022-09-28 | Eingeleitet | Truist | Buy |
| 2022-01-25 | Hochstufung | Berenberg | Hold → Buy |
| 2022-01-19 | Eingeleitet | Bernstein | Mkt Perform |
| 2021-08-26 | Hochstufung | UBS | Sell → Neutral |
| 2020-04-01 | Fortgesetzt | Goldman | Sell |
| 2020-03-09 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-15 | Herabstufung | CFRA | Hold → Sell |
| 2019-09-20 | Eingeleitet | MKM Partners | Neutral |
| 2019-09-19 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-09 | Herabstufung | Goldman | Neutral → Sell |
| 2018-12-13 | Eingeleitet | UBS | Neutral |
| 2018-09-07 | Eingeleitet | Jefferies | Hold |
| 2018-06-28 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2018-06-12 | Herabstufung | Societe Generale | Hold → Sell |
| 2018-03-07 | Hochstufung | Pivotal Research Group | Hold → Buy |
| 2018-01-10 | Eingeleitet | Barclays | Equal Weight |
| 2017-12-07 | Hochstufung | Societe Generale | Sell → Hold |
Alle ansehen
Brown Forman Corporation Aktie (BF.B) Neueste Nachrichten
What Is Behind Brown-Forman (NYSE:BF-B) Dividend Questions Today? - Kalkine Media
Zacks Industry Outlook Anheuser-Busch InBev, Constellation Brands, Brown-Forman and Molson Coors - Zacks Investment Research
5 Alcohol Stocks to Watch as Innovation Fuels Industry Growth - Zacks Investment Research
Will Brown Forman (NYSE:BF.B) Navigate the Next Market Test? - Kalkine Media
Brown-Forman (NYSE:BF.B): Can Jack Daniel's Weather the Spirits Slowdown? - Kalkine Media
SAM Pushes Innovation: Can New Cocktails & Coolers Gain Traction? - Zacks Investment Research
Brown-Forman B (BF.B) Down 5.6% Since Last Earnings Report: Can It Rebound? - Zacks Investment Research
Return on invested capital % of Brown-Forman Corporation Class B – HAN:BF5B - tradingview.com
Brown-Forman Corporation Class B Balance Sheet – HAN:BF5B - tradingview.com
Brown-Forman Corporation Class B Cash Flow – HAN:BF5B - tradingview.com
Brown-Forman stock at USD 26.39 on September 28, 2026 - AD HOC NEWS
Brown-Forman Corporation (BF-A) Stock Price, News, Quote & History - Yahoo! Finance Canada
Brown-Forman Corporation (BF-B) Stock Price, News, Quote & History - Yahoo! Finance Canada
Brown-Forman stock steadies after sell rating as $500 million debt deal highlights funding strategy - AD HOC NEWS
Brown-Forman stock slips after sell rating as earnings loom - AD HOC NEWS
Brown-Forman stock edges higher as new $500 million notes expand funding flexibility - AD HOC NEWS
Brown-Forman stock holds near recent lows as Q1 FY27 margins face pressure - AD HOC NEWS
Whiskey Whiffs, But Brown-Forman Sees Promise in New Mix - Benzinga
Brown-Forman stock gains as $500 million debt offering highlights funding strategy - AD HOC NEWS
Brown-Forman stock gains after conference appearance and recent earnings - ad-hoc-news.de
Brown-Forman stock heads into the open after a 1.6% gain - ad-hoc-news.de
Brown-Forman stock holds steady as latest figures show modest sales decline - AD HOC NEWS
The 7 Best Dividend Aristocrats to Buy Now for the Long Term - morningstar.com
Brown-Forman at barclays consumer conference: growth plan gains confidence - investing.com
Transcript : Brown-Forman Corporation Presents at Barclays 19th Annual Global Consumer Staples Conference, Sep-09-2026 12:45 PM - marketscreener.com
Brown-Forman at barclays consumer conference: growth plan gains confidence - Investing.com India
Brown-Forman: Strong Fundamentals Make It Attractive Even Without A Buyout (NYSE:BF.B) - Seeking Alpha
Brown-Forman adds Switzerland to Coca-Cola HBC tie-ups - Yahoo Finance
Brown-Forman stock stays near a 52-week low after Q1 miss - ad-hoc-news.de
Brown-Forman stock heads into the open after a recent slide - ad-hoc-news.de
Brown-Forman revives historic ‘Kentucky Boy’ bourbon to honor master distiller - WKYT
Brown-Forman Corp. Cl B stock outperforms competitors despite losses on the day - MarketWatch
Brown-Forman stock trades near a 52-week low - ad-hoc-news.de
Brown-Forman Revives ‘Kentucky Boy’ Bourbon - Breaking Bourbon
Brown-Forman Revives ‘Kentucky Boy’ Bourbon, Honoring Master Distiller Chris Morris’ 50-Year Legacy - Brown-Forman
Brown-Forman Revives ‘Kentucky Boy’ Bourbon, Honoring Master Distiller Chris Morris’ 50-Year Legacy - itemonline.com
A bourbon returns to honor a distiller's 50-year career. Brown-Forman's Kentucky Boy is a one-time release. - stocktitan.net
Brown-Forman Revives ‘Kentucky Boy’ Bourbon, Honoring Master Distiller Chris Morris’ 50-Year Legacy - FinancialContent
Brown-Forman Still Trading at Valuation Multiples Not Seen Since the Subprime Crisis - marketscreener.com
Brown-Forman stock holds steady after quarterly earnings meet estimates - ad-hoc-news.de
Brown-Forman stock holds steady as investors focus on stable earnings and dividend - ad-hoc-news.de
How Investors Are Reacting To Brown-Forman (BF.B) CEO Retirement And Flat Organic Sales Outlook - simplywall.st
How Investors Are Reacting To Brown-Forman (BF.B) CEO Retirement And Flat Organic Sales Outlook - simplywall.st
Brown-Forman Corp. Cl B stock underperforms Friday when compared to competitors - MarketWatch
UBS Adjusts Price Target on Brown-Forman to $30 From $27, Keeps Neutral Rating - marketscreener.com
Brown-Forman rejects Sazerac acquisition proposal - scanx.trade
Brown-Forman Q1 Solid Despite Challenging Spirits Market, RBC Says - Moomoo
Brown Forman (BF.B) Stock Sees RTD Gains Clash With Flat Growth Outlook - simplywall.st
Brown-Forman Corp. Cl B stock outperforms competitors on strong trading day - MarketWatch
Brown-Forman Defends Strategy After Rejecting Sazerac Takeover, Reported Family Dispute - Yahoo Finance
Finanzdaten der Brown Forman Corporation-Aktie (BF.B)
Es liegen keine Finanzdaten für Brown Forman Corporation (BF.B) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Brown Forman Corporation-Aktie (BF.B) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Whiting Lawson E | President & CEO |
Dec 12 '25 |
Sale |
31.00 |
8,834 |
273,854 |
32,933 |
| Whiting Lawson E | President & CEO |
Dec 04 '25 |
Sale |
31.01 |
12,531 |
388,538 |
2 |
| Whiting Lawson E | Officer |
Dec 04 '25 |
Proposed Sale |
31.00 |
42,495 |
1,317,345 |
0 |
| Whiting Lawson E | Officer |
Dec 04 '25 |
Proposed Sale |
30.97 |
4,785 |
148,185 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):